Jenna J. Guthmiller

University of Chicago - Department of Medicine

1101 East 58th Street

Chicago, IL 60637

United States

SCHOLARLY PAPERS

3

DOWNLOADS

62

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Integrated COVID-19 Convalescent Plasma Treatment and Antibody Research Program at a Single Academic Medical Center

Number of pages: 22 Posted: 16 Jun 2020
University of Chicago - Department of Surgery, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Pathology, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Pathology, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Medicine, University of Chicago - Committee on Immunology, University of Chicago - Committee on Immunology, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Clinical Microbiology and Immunology Laboratory, University of Chicago - Clinical Microbiology and Immunology Laboratory, University of Chicago - Department of Pathology, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Medicine, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Medicine, University of Chicago - Department of Surgery and University of Chicago - Department of Surgery
Downloads 48 (429,141)

Abstract:

Loading...

COVID-19; convalescent plasma; antibody; whole blood collection; redeployment of existing resources

2.

Clinical Predictors of Donor Antibody Titer and Correlation with Recipient Antibody Response in a COVID-19 Convalescent Plasma Clinical Trial

Number of pages: 30 Posted: 06 Aug 2020
University of Chicago - Department of Surgery, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Pathology, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Pathology, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Committee on Immunology, University of Chicago - Committee on Immunology, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Clinical Microbiology and Immunology Laboratory, University of Chicago - Clinical Microbiology and Immunology Laboratory, University of Chicago - Department of Public Health Sciences, University of Chicago - Department of Pathology, University of Chicago - Department of Surgery, University of Chicago - Departments of Medicine and Economics, and Harris School, University of Chicago - Department of Surgery, University of Chicago - Department of Medicine, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Surgery, University of Chicago - Department of Medicine, University of Chicago - Department of Surgery and University of Chicago - Department of Surgery
Downloads 7 (662,336)

Abstract:

Loading...

convalescent plasma; COVID-19; antibody; clinical trial

3.

Polyreactive Broadly Neutralizing B Cells are Selected to Provide Defense Against Pandemic Threat Influenza Viruses

Number of pages: 43 Posted: 30 Jun 2020
University of Chicago - Department of Medicine, University of Chicago - Committee on Immunology, The Scripps Research Institute - Center for Molecular Biosciences Innsbruck, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Committee on Immunology, University of Chicago - Department of Medicine, Icahn School of Medicine at Mount Sinai - Department of Microbiology, University of Chicago - Committee on Immunology, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, University of Chicago - Department of Medicine, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Innsbruck - Center for Molecular Biosciences Innsbruck and University of Chicago - Department of Medicine
Downloads 7 (655,127)

Abstract:

Loading...

Polyreactivity, broadly neutralizing antibodies, influenza viruses, monoclonal antibodies